MEI Pharma

MEI Pharma

MEI Pharma Company(Nasdaq: MEIP)

Circa MEI Pharma

Fondato

2018

Notizie

MEI Pharma, Inc.(Nasdaq: MEIP) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

Dettagli sul fundrasing

Round di finanziamentoAmountValutazione
Ora
Investitori
Post-IPO
$100.00M
--
2025-07-21
--